Table 4.

Clinical characteristics of correctly classified and misclassified controls and Parkinson’s disease (PD) participants.

		Controls			PD
		False Positive	True Negative	$\mathit{p}$	False Negative	True Positive	$\mathit{p}$
All PD
	UPDRS_PIII	–	–	–	15.8 ± 8.3	22.5 ± 11.8	0.006
	MoCA	–	–	–	28.6 ± 2.5	27.3 ± 3.0	0.075
	CIRS-G	–	–	–	4.7 ± 4.3	4.9 ± 3.4	0.88
	Age	70.9 ± 7.3	62.6 ± 7.3	0.006	65.9 ± 6.8	66.9 ± 9.3	0.30
	Sex (% male)	11.1	36.0	0.10	50.0	63.3	0.33
	Medication state (% ON)	–	–	–	85.7	70.6	0.44
	H&Y (n)			–			0.47
	1				1	11
	1.5				1	3
	2				10	159
	2.5				1	34
	3				1	24
	4				0	17
Mild PD
	UPDRS_PIII	–	–	–	13.7 ± 7.4	18.7 ± 9.6	0.03
	MoCA	–	–	–	28.1 ± 1.9	27.5 ± 2.8	0.36
	CIRS-G	–	–	–	4.9 ± 4.4	4.4 ± 3.1	0.72
	Age	71.5 ± 6.3	61.3 ± 6.3	4.0 × 10−5	65.2 ± 9.1	69.2 ± 7.5	0.12
	Sex (% male)	42.9	36.1	0.71	45.5	60.9	0.32
	Medication state (% ON)	–	–	–	88.2	71.3	0.36
	H&Y (n)			–			0.38
	1				1	11
	1.5				1	3
	2				9	160